AU2004312548A1 - Targeted immunogens - Google Patents

Targeted immunogens Download PDF

Info

Publication number
AU2004312548A1
AU2004312548A1 AU2004312548A AU2004312548A AU2004312548A1 AU 2004312548 A1 AU2004312548 A1 AU 2004312548A1 AU 2004312548 A AU2004312548 A AU 2004312548A AU 2004312548 A AU2004312548 A AU 2004312548A AU 2004312548 A1 AU2004312548 A1 AU 2004312548A1
Authority
AU
Australia
Prior art keywords
sequence
seq
amino acid
hper1
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004312548A
Other languages
English (en)
Inventor
Scott Gallichan
Danielle Salha
A. Robert Uger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SANOFI PASTEUR Inc
Original Assignee
SANOFI PASTEUR Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SANOFI PASTEUR Inc filed Critical SANOFI PASTEUR Inc
Publication of AU2004312548A1 publication Critical patent/AU2004312548A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2004312548A 2003-12-31 2004-12-30 Targeted immunogens Abandoned AU2004312548A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53372803P 2003-12-31 2003-12-31
US60/533,728 2003-12-31
PCT/US2004/044023 WO2005066203A2 (en) 2003-12-31 2004-12-30 Targeted immunogens

Publications (1)

Publication Number Publication Date
AU2004312548A1 true AU2004312548A1 (en) 2005-07-21

Family

ID=34748948

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004312548A Abandoned AU2004312548A1 (en) 2003-12-31 2004-12-30 Targeted immunogens

Country Status (12)

Country Link
US (1) US20060002946A1 (enExample)
EP (1) EP1699492A2 (enExample)
JP (1) JP2007536911A (enExample)
KR (1) KR20060129353A (enExample)
CN (1) CN1921889A (enExample)
AU (1) AU2004312548A1 (enExample)
BR (1) BRPI0418273A (enExample)
CA (1) CA2552251A1 (enExample)
IL (1) IL176603A0 (enExample)
MX (1) MXPA06007574A (enExample)
WO (1) WO2005066203A2 (enExample)
ZA (1) ZA200605304B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103110D0 (en) * 2000-08-25 2001-03-28 Aventis Pharma Inc A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1
WO2012123755A1 (en) 2011-03-17 2012-09-20 The University Of Birmingham Re-directed immunotherapy
KR20170116039A (ko) * 2015-02-18 2017-10-18 에프. 호프만-라 로슈 아게 표적 세포에 대항하여 t 세포 세포독성을 특이적으로 유도하기 위한 면역컨주게이트
CA2984629C (en) 2015-05-07 2024-06-18 University Of South Florida Modified ube3a gene for a gene therapy approach for angelman syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE391791T1 (de) * 2000-08-25 2008-04-15 Aventis Pharma Inc Membran penetrierende peptide und deren anwendungen
CA2477429A1 (en) * 2002-01-29 2003-08-07 Robert A. Uger Targeted immunogens

Also Published As

Publication number Publication date
WO2005066203A2 (en) 2005-07-21
IL176603A0 (en) 2006-10-31
US20060002946A1 (en) 2006-01-05
CN1921889A (zh) 2007-02-28
WO2005066203A3 (en) 2005-09-01
JP2007536911A (ja) 2007-12-20
BRPI0418273A (pt) 2007-05-02
EP1699492A2 (en) 2006-09-13
MXPA06007574A (es) 2007-04-17
KR20060129353A (ko) 2006-12-15
CA2552251A1 (en) 2005-07-21
ZA200605304B (en) 2007-12-27

Similar Documents

Publication Publication Date Title
KR100731820B1 (ko) 치료적 백신화를 위한 새로운 방법
AU2011200127B2 (en) Multi-antigen vectors for melanoma
US20110311543A1 (en) Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer
US8207314B2 (en) Tumor antigens for prevention and/or treatment of cancer
US8530442B2 (en) Modified CEA nucleic acid and expression vectors
EP1864691B1 (en) Modified CEA nucleic acid and expression vectors
US20040002455A1 (en) Targeted immunogens
US20030113919A1 (en) Immunogenic targets for melanoma
US20030148973A1 (en) MAGE-A1 peptides for treating or preventing cancer
US20060002946A1 (en) Targeted immunogens
AU2010224381B2 (en) Tumor antigens BFA4 and BCY1 for prevention and/or treatment of cancer
AU2004280608B2 (en) Modified CEA/B7 vector
AU2003216119A1 (en) Targeted immunogens
CN1878566B (zh) 用于黑素瘤的多抗原载体
CA2481719C (en) Modified cea nucleic acid and expression vectors
HK1102553A (en) Targeted immunogens
US20090156519A1 (en) Modified KSA and Uses Thereof
MXPA06002477A (en) Multi-antigen vectors for melanoma

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application